Nanoparticles for Bone Mineralization via miRNA Regulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for enhancing bone mineralization and gene expression in bone cells are limited in efficacy and understanding, particularly in using nanostructural materials that interact with cells and tissues for accelerated tissue regeneration and cellular proliferation.

Innovation Solution

A method involving the use of nanoparticles such as silver nanoparticles, single-walled carbon nanotubes, hydroxyapatite nanoparticles, and titanium dioxide nanoparticles to induce mineralization in bone cells, which can be administered to subjects with bone diseases or fractures, promoting bone healing and formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to enhance bone mineralization and gene expression, then some level of bone formation is achieved, but the efficacy and understanding of the process are limited

Engineering Contradiction:
Improveefficacy of bone mineralizationVSAvoidunderstanding of gene expression mechanisms
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent changes the scale parameter by using nanoscale materials (1-100 nm) instead of conventional macroscopic materials. This parameter change enables new interactions with cellular structures, significantly improving bone mineralization efficacy while allowing researchers to observe and understand gene expression mechanisms at previously inaccessible scales through advanced characterization techniques

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite nanomaterials combining different inorganic components (hydroxyapatite, titanium dioxide, silver nanoparticles) with organic matrices. These composites achieve synergistic effects that enhance both bone mineralization efficacy and provide multiple pathways for studying gene expression regulation, thereby addressing both limitations simultaneously

Inventive Principle:
Principle #40Composite materials

2Productivity

If nanoscale materials are used to interact with cells and tissues for accelerated tissue regeneration, then cellular proliferation is enhanced, but the complexity of material-cell interactions increases

Engineering Contradiction:
Improvetissue regeneration rateVSAvoidcomplexity of nanomaterial-cell interactions
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies local quality by designing nanomaterials with specific surface properties, sizes, and shapes tailored to interact with particular cellular structures. For example, hydroxyapatite nanoparticles with specific crystal orientations are used to target osteoblast differentiation pathways, enhancing tissue regeneration while reducing unnecessary complex interactions with other cellular components

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent introduces surface-modified nanomaterials as intermediaries between external stimulation and cellular responses. The nanomaterial surfaces are functionalized with specific ligands or coatings that mediate controlled interactions with cell surface receptors, enabling accelerated tissue regeneration through defined signaling pathways while simplifying the overall interaction complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS9074187B2Nanostructural materials that increase mineralization in bone cells and affect gene expression through miRNA regulation and applications of same
Publication Date: 2015.07.07 THE BOARD OF TRUSTEES OF THE UNIV OF ARKANSAS
  • US9074187B2 patent drawing
  • US9074187B2 patent drawing
  • US9074187B2 patent drawing

AI summary

A method of inducing mineralization in a bone cell is described. The method comprises contacting a bone cell with a composition comprising nanoparticles. The nanoparticles can be single-walled carbon nanotubes, hydroxyapatite nanoparticles, TiO2 nanoparticles or silver nanoparticles. The bone cell can be an osteoblast cell. A method for increasing bone mass, bone healing or bone formation is also described which comprises administering to a subject in need thereof an effective amount of a composition comprising nanoparticles. The subject can suffer from a bone disease such as osteoporosis. The subject can suffer from a bone fracture and the method can comprise contacting bone cells near the bone fracture site with the composition. The composition can further comprise a pharmaceutically acceptable carrier.